Association between urine uranium and asthma prevalence.

Front Public Health

Department of Pulmonary and Critical Care Medicine, Jinhua Municipal Central Hospital, Jinhua, China.

Published: January 2024


Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Background: Previous studies showed that urine uranium (U) is associated with asthma prevalence in adults. However, the association between them among the general population is unclear. Therefore, this study aimed to explore this unclear association.

Methods: The data of the participants were collected from the 2007-2016 National Health and Nutrition Examination Survey (NHANES) performed in the United States. Continuous variables with a skewed distribution were analyzed using Ln-transformation. The association between urine U and asthma prevalence was analyzed by multiple regression analysis, and the linear association between them was evaluated by smoothed curve fitting. The subgroup analysis was performed using the hierarchical multivariate regression analysis.

Results: A total of 13,581 participants were included in our analysis. The multivariate regression analysis showed that LnU was independently and positively correlated with asthma prevalence in the general population (OR = 1.12; 95% CI: 1.04-1.20;  = 0.002). The subgroup analysis revealed that college graduate or above showed a stronger association between LnU and asthma prevalence (<9th grade: OR = 0.84; 95% CI: 0.61-1.14; 9-11th grade: OR = 1.23; 95% CI: 0.99-1.52; high school grade: OR = 1.00; 95% CI: 0.84-1.19; college: OR = 1.04; 95% CI: 0.91-1.19; ≥college graduate: OR = 1.32; 95% CI: 1.11-1.57; for interaction = 0.0389).

Conclusion: Our research suggested that urinary U levels are positively associated with asthma prevalence among the general population of the United States, and the association is especially strong among people with high levels of education.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10800476PMC
http://dx.doi.org/10.3389/fpubh.2023.1326258DOI Listing

Publication Analysis

Top Keywords

asthma prevalence
20
association urine
8
urine uranium
8
general population
8
regression analysis
8
subgroup analysis
8
multivariate regression
8
association
5
asthma
5
prevalence
5

Similar Publications

Aims And Objectives: To evaluate the efficacy of YoungAsthma, a nurse-led, web-based mHealth intervention on asthma control and self-efficacy among adolescents with asthma utilizing decision tree analysis.

Background: Asthma is a prevalent chronic condition in pediatric populations, necessitating sustained management for optimal disease control.

Design: A randomized controlled clinical trial.

View Article and Find Full Text PDF

Background: Airway obstruction is a characteristic spirometric finding in asthma but the clinical significance of other abnormal spirometric patterns is less well described. We aimed to explore pre- and post-bronchodilator (BD) prevalences and clinical characteristics of preserved ratio impaired spirometry (PRISm), dysanapsis and airflow obstruction with low forced expiratory volume in 1 s (FEV) in children diagnosed with asthma.

Methods: We extracted specialist care data (clinical and spirometry) from the Swedish National Airway Register (n=3301, age 5-17 years).

View Article and Find Full Text PDF

Predictors of mortality and hospitalised exacerbations in obstructive airway diseases.

ERJ Open Res

September 2025

Department of Bioanalysis, Pharmaceutical Care Unit, Faculty of Pharmaceutical Sciences, Ghent University, Ghent, Belgium.

Background: In Belgium, age-standardised hospital admission and mortality rates for asthma and COPD are higher than the European average. Understanding the factors that lead to a hospitalised exacerbation and/or mortality is needed to optimise patient management.

Methods: Patients ≥18 years old obtaining two claims for drugs for obstructive airway diseases (ATC code R03) in 1 year between 2017 and 2022 were identified in Belgian nationwide claims-based data.

View Article and Find Full Text PDF

Background And Purpose: Biologics are crucial for severe asthma treatment, but their high costs pose challenges. Omalizumab (OML) is dosed on the basis of patient-specific factors. The purpose of this study is to clarify the clinical characteristics of severe asthmatics who maintain long-term control on omalizumab including healthcare cost considerations.

View Article and Find Full Text PDF